Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pliant Therapeutics (PLRX) Treasury Shares (2019 - 2025)

Pliant Therapeutics (PLRX) has disclosed Treasury Shares for 7 consecutive years, with $858247.0 as the latest value for Q4 2025.

  • Quarterly Treasury Shares changed N/A to $858247.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $858247.0 through Dec 2025, changed N/A year-over-year, with the annual reading at $858247.0 for FY2025, N/A changed from the prior year.
  • Treasury Shares for Q4 2025 was $858247.0 at Pliant Therapeutics, down from $1.0 million in the prior quarter.
  • The five-year high for Treasury Shares was $1.3 million in Q1 2025, with the low at $6235.0 in Q1 2022.
  • Average Treasury Shares over 5 years is $561252.6, with a median of $354533.0 recorded in 2022.
  • The sharpest move saw Treasury Shares crashed 93.52% in 2022, then soared 18641.56% in 2023.
  • Over 5 years, Treasury Shares stood at $37838.0 in 2021, then surged by 836.97% to $354532.0 in 2022, then soared by 146.73% to $874748.0 in 2023, then rose by 8.73% to $951127.0 in 2024, then decreased by 9.77% to $858247.0 in 2025.
  • According to Business Quant data, Treasury Shares over the past three periods came in at $858247.0, $1.0 million, and $1.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.